Nevirapine (NSC 641530)

Catalog No.S1742 Batch:S174201

Print

Technical Data

Formula

C15H14N4O
Molecular Weight 266.3 CAS No. 129618-40-2
Solubility (25°C)* In vitro DMSO 53 mg/mL (199.02 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Nevirapine (NSC 641530, NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.
Targets
Reverse transcriptase [1]
In vitro

Nevirapine (NSC 641530) is a non-nucleoside RT inhibitor with a well-characterized inhibitory activity on RT enzymes of retroviral origin. It is also an effective inhibitor of the endogenous RT in murine and human cell lines. This compound is a highly specific inhibitor of HIV-1 reverse transcriptase (RT) which exhibits an IC50 = 84 nM in enzyme assays and IC50 = 40nM against HIV-1 replication in cell culture. It alters the cleavage specificity of the RNase H, resulting in Nevirapine-induced stimulation of RNase H activity beyond the increase expected from the change in cleavage specificity. It is an inhibitor of only CYP3A4 at concentrations that are well above those of therapeutic relevance (Ki = 270 mM). Its exposure rescues the differentiation block present in acute myeloid leukemia (AML) cell lines and primary blasts from two AML patients, as indicated by morphological, functional and immunophenotypic assays.

In vivo

Nevirapine (NSC 641530) is metabolized to 4-CANVP as a major metabolite in all male animals and in female mice, dogs, and monkeys. 3-OHNVP is a major fecal metabolite in all animals except for the male rat. In the bile of rats, 4-CANVP is a major metabolite along with 12-OHNVP glucuronide.

Protocol (from reference)

References

  • https://pubmed.ncbi.nlm.nih.gov/10570031/
  • https://pubmed.ncbi.nlm.nih.gov/12747369/
  • https://pubmed.ncbi.nlm.nih.gov/1371691/
  • https://pubmed.ncbi.nlm.nih.gov/7533167/
  • https://pubmed.ncbi.nlm.nih.gov/10570025/

Customer Product Validation

Cells were inoculated with 0.05 ng mock-exposed and semen-exposed HIV, and 0.5 ng HIV as infectivity-matched control. Infection rates were measured 3 d post infection by measuring β-galactosidase. Left: the mean enzyme activities. Middle: normalized infection rates in which reporter enzyme activities obtained from infected cells in the absence of nevirapine were set at 100%. Right: IC50 values.

Data from [ , , Sci Transl Med, 2014, 6(262): 262ra157 ]

Selleck's Nevirapine (NSC 641530) Has Been Cited by 18 Publications

LINE-1 activation in the cerebellum drives ataxia [ Neuron, October 19, 2022, 3278-3287.e8] PubMed: 36070749
In vitro comparison of the susceptibilities of the same drug resistance mutations to reverse-transcriptase inhibitors of subtype B and CRF01_AE HIV-1 strains [ Scientific Reports, October 15, 2025, 15(1)] PubMed: 41093949
Bcl-2 Antagonist Obatoclax Reactivates Latent HIV-1 via the NF-κB Pathway and Induces Latent Reservoir Cell Apoptosis in Latently Infected Cells [ ACS Infectious Diseases, November 10, 2023, 2105-2118] PubMed: 37796279
PARP1 depletion induces RIG-I-dependent signaling in human cancer cells [ PLoS One, March 28, 2018, e0194611] PubMed: 29590171
Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities [ Biomolecules, July 9, 2024, 819] PubMed: 39062532
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways [ Nat Commun, 2024, 15(1):9321] PubMed: 39472584
Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities [ Biomolecules, 2024, 14(7)819] PubMed: 39062532
Biological and Structural Analyses of New Potent Allosteric Inhibitors of HIV-1 Integrase [ Antimicrob Agents Chemother, 2023, 67(7):e0046223] PubMed: 37310224
DNA ultra-sensitive quantification, a technology for studying HIV unintegrated linear DNA [ Cell Rep Methods, 2023, 3(4):100443] PubMed: 37159665
LINE-1 activation in the cerebellum drives ataxia [ Neuron, 2022, 110(20):3278-3287.e8] PubMed: 36070749

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.